Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.
Pfizer Battles to Protect Lipitor Cash Cow
Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.
FDA’s Abrams Spends 4 Minutes Discussing Social Media Guidance at ePharma Summit!
This just in: FDA Won't Issue Specific Guidance for Youtube, Facebook, or Twitter. Claims These Media Are Just Passing Fads! Now Back to Your Regularly-Scheduled TV Ad.
Evidence-Based Pharma Marketing: Using Science to Demonstrate Product Value
A conversation with Preeti Pinto, Principal at Preeti Pinto Consulting, LLC and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca US, about the use of comparative effectiveness and health outcomes data in the support of drug promotion to physicians, payers, and consumers.
Pharma Marketing News Vol. 10, No. 14: 22 September 2011
Welcome to Volume 10, Issue #14 (22 SEPTEMBER 2011) of Pharma Marketing News.
Checking Under the Hood of Pharma Mobile Apps
Let's look 'under the hoods' of two pharma-sponsored mobile apps and compare disclaimers. We'll compare Janssen's PASI calculator, which has an update disclaimer, with the new AFib Educator 2.0 app developed by Sanofi-Aventis.
Digitally-Feeble Pharma
Is Your Brand a Digital Genius or a Feeble-Minded Idiot? When it comes to digital IQ, some brands are geniuses and some are feeble-minded idiots, according to the 'L2 Digital IQ Index' for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories.
Are Pharma Sales Reps Service Employees?
The Supreme Court has agreed to decide whether drug companies have to pay their sales representatives for working overtime hours, a question that could have considerable financial impact on the industry. The question before the court in case CHRISTOPHER V. SMITHKLINE BEECHAM CORP is whether or not pharmaceutical sales representatives are exempt from overtime pay under the 'outside sales' exemption of the Fair Labor Standards Act of 1938. If the Supreme Court rules that pharma sales reps are NOT exempt, some sales reps worry that they will become
PhRMA Masters the Art of “Proofiness!”
In a recent video titled 'What Gets PhRMA's Chairman Up Every Morning?', Chris Viehbacher, CEO of Sanofi, cited an impressive Potemkin number related to life expectancy and the pharma industry.
Pharma Marketing News Vol. 10, No. 12: 20 July 2011
Welcome to Volume 10, Issue #12 (20 JULY 2011) of Pharma Marketing News.
